# Recombinant Zoster Vaccine in Stable SLE Patients

> **NCT04516408** · NA · UNKNOWN · sponsor: **RenJi Hospital** · enrollment: 464 (estimated)

## Conditions studied

- Herpes Zoster
- Recombinant Zoster Vaccine
- Systemic Lupus Erythematosus

## Interventions

- **BIOLOGICAL:** Recombinant zoster vaccine
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT04516408
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-20
- **Primary completion:** 2023-09-30
- **Final completion:** 2023-09-30
- **Target enrollment:** 464 (ESTIMATED)
- **Last updated:** 2022-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04516408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04516408, "Recombinant Zoster Vaccine in Stable SLE Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04516408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*